Skip to content
Disclosery

ORBIMED ADVISORS LLC: OVID position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on OVID, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 747,000 OVID shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 747,000 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $2,009,430.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec ยง4.2).